1658TiP The STAMPEDE2 177Lutetium-PSMA-617 (177Lu-PSMA-617) trial: A phase III, randomised, open-label trial in patients with metastatic prostate cancer (mPC) starting androgen deprivation therapy (ADT).
Saved in:
| Title: | 1658TiP The STAMPEDE2 177Lutetium-PSMA-617 (177Lu-PSMA-617) trial: A phase III, randomised, open-label trial in patients with metastatic prostate cancer (mPC) starting androgen deprivation therapy (ADT). |
|---|---|
| Authors: | Padden-Modi, M.1 (AUTHOR), Abdel-Aty, H.1 (AUTHOR), Jones, C.2 (AUTHOR), Brown, L.C.3 (AUTHOR), Dutey-Magni, P.3 (AUTHOR), Yogeswaran, Y.3 (AUTHOR), Horsey, A.3 (AUTHOR), Amos, C.L.3 (AUTHOR), Murray, I.4 (AUTHOR), Hujairi, N.5 (AUTHOR), Tunariu, N.6 (AUTHOR), Millman, R.3 (AUTHOR), Cross, W.7 (AUTHOR), Kasivisvanathan, V.8 (AUTHOR), Parmar, M.K.3 (AUTHOR), Clarke, N.2 (AUTHOR), Gillessen, S.9 (AUTHOR), Attard, G.10 (AUTHOR), Parker, C.11 (AUTHOR), James, N.D.1 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS999-S1000. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 179693101 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1658TiP The STAMPEDE2 177Lutetium-PSMA-617 (177Lu-PSMA-617) trial: A phase III, randomised, open-label trial in patients with metastatic prostate cancer (mPC) starting androgen deprivation therapy (ADT). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Padden-Modi%2C+M%2E%22">Padden-Modi, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abdel-Aty%2C+H%2E%22">Abdel-Aty, H.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jones%2C+C%2E%22">Jones, C.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brown%2C+L%2EC%2E%22">Brown, L.C.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dutey-Magni%2C+P%2E%22">Dutey-Magni, P.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yogeswaran%2C+Y%2E%22">Yogeswaran, Y.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Horsey%2C+A%2E%22">Horsey, A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Amos%2C+C%2EL%2E%22">Amos, C.L.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Murray%2C+I%2E%22">Murray, I.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hujairi%2C+N%2E%22">Hujairi, N.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tunariu%2C+N%2E%22">Tunariu, N.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Millman%2C+R%2E%22">Millman, R.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cross%2C+W%2E%22">Cross, W.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kasivisvanathan%2C+V%2E%22">Kasivisvanathan, V.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Parmar%2C+M%2EK%2E%22">Parmar, M.K.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Clarke%2C+N%2E%22">Clarke, N.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gillessen%2C+S%2E%22">Gillessen, S.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Attard%2C+G%2E%22">Attard, G.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Parker%2C+C%2E%22">Parker, C.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22James%2C+N%2ED%2E%22">James, N.D.</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS999-S1000. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179693101 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2024.08.1739 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S999 Titles: – TitleFull: 1658TiP The STAMPEDE2 177Lutetium-PSMA-617 (177Lu-PSMA-617) trial: A phase III, randomised, open-label trial in patients with metastatic prostate cancer (mPC) starting androgen deprivation therapy (ADT). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Padden-Modi, M. – PersonEntity: Name: NameFull: Abdel-Aty, H. – PersonEntity: Name: NameFull: Jones, C. – PersonEntity: Name: NameFull: Brown, L.C. – PersonEntity: Name: NameFull: Dutey-Magni, P. – PersonEntity: Name: NameFull: Yogeswaran, Y. – PersonEntity: Name: NameFull: Horsey, A. – PersonEntity: Name: NameFull: Amos, C.L. – PersonEntity: Name: NameFull: Murray, I. – PersonEntity: Name: NameFull: Hujairi, N. – PersonEntity: Name: NameFull: Tunariu, N. – PersonEntity: Name: NameFull: Millman, R. – PersonEntity: Name: NameFull: Cross, W. – PersonEntity: Name: NameFull: Kasivisvanathan, V. – PersonEntity: Name: NameFull: Parmar, M.K. – PersonEntity: Name: NameFull: Clarke, N. – PersonEntity: Name: NameFull: Gillessen, S. – PersonEntity: Name: NameFull: Attard, G. – PersonEntity: Name: NameFull: Parker, C. – PersonEntity: Name: NameFull: James, N.D. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2024 Supplement 2 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 35 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |